Literature DB >> 8200619

Fatty acid synthesis in obese insulin resistant diabetic mice.

R A Memon1, C Grunfeld, A H Moser, K R Feingold.   

Abstract

Diabetes is associated with hypertriglyceridemia and it has been suggested that the intestine contributes to this elevation. Recent studies have shown that in animals with IDDM, fatty acid (FA) synthesis is decreased in the liver and increased in the small intestine (SI). The purpose of the present study was to measure FA synthesis in the liver and SI of animals with NIDDM. In both db/db and ob/ob animals the incorporation of 3H2O into FA was increased in the SI (10 fold in db/db and 2.2 fold in ob/ob). FA synthesis was also increased in the liver of NIDDM (9 fold in db/db and 6 fold in ob/ob). These results provide further evidence that diabetes leads to changes in lipid metabolism in the SI.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200619     DOI: 10.1055/s-2007-1000778

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  9 in total

1.  FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice.

Authors:  Jingqing Chen; Xihong Zhou; Weiche Wu; Xinxia Wang; Yizhen Wang
Journal:  J Physiol Biochem       Date:  2015-06-16       Impact factor: 4.158

2.  Dissociation between adipose tissue fluxes and lipogenic gene expression in ob/ob mice.

Authors:  S M Turner; S Roy; H S Sul; R A Neese; E J Murphy; W Samandi; D J Roohk; M K Hellerstein
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-12-12       Impact factor: 4.310

Review 3.  Molecular mediators of hepatic steatosis and liver injury.

Authors:  Jeffrey D Browning; Jay D Horton
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

4.  TAp63 is a master transcriptional regulator of lipid and glucose metabolism.

Authors:  Xiaohua Su; Young Jin Gi; Deepavali Chakravarti; Io Long Chan; Aijun Zhang; Xuefeng Xia; Kenneth Y Tsai; Elsa R Flores
Journal:  Cell Metab       Date:  2012-10-03       Impact factor: 27.287

5.  CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice.

Authors:  Fatiha Nassir; Okunade L Adewole; Elizabeth M Brunt; Nada A Abumrad
Journal:  J Lipid Res       Date:  2013-08-20       Impact factor: 5.922

6.  Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis.

Authors:  Brendan N Reid; Gene P Ables; Oleg A Otlivanchik; Gabriele Schoiswohl; Rudolf Zechner; William S Blaner; Ira J Goldberg; Robert F Schwabe; Streamson C Chua; Li-Shin Huang
Journal:  J Biol Chem       Date:  2008-03-12       Impact factor: 5.157

Review 7.  The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease.

Authors:  Grace Park; Sunhee Jung; Kathryn E Wellen; Cholsoon Jang
Journal:  Exp Mol Med       Date:  2021-05-20       Impact factor: 8.718

8.  Differential effect of corn oil-based low trans structured fat on the plasma and hepatic lipid profile in an atherogenic mouse model: comparison to hydrogenated trans fat.

Authors:  Yun-Young Cho; Eun-Young Kwon; Hye-Jin Kim; Seon-Min Jeon; Ki-Teak Lee; Myung-Sook Choi
Journal:  Lipids Health Dis       Date:  2011-01-20       Impact factor: 3.876

9.  Intestinal mucosal triacylglycerol accumulation secondary to decreased lipid secretion in obese and high fat fed mice.

Authors:  John D Douglass; Nashmia Malik; Su-Hyoun Chon; Kevin Wells; Yin Xiu Zhou; Andrew S Choi; Laurie B Joseph; Judith Storch
Journal:  Front Physiol       Date:  2012-02-24       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.